AbbVie Inc. (NYSE:ABBV)

20 Dividend Stocks for All Baby Boomers to Retire On

It may not be a secret that investors love dividends, but many retirees absolutely have no choice but to invest in strong dividend stocks that have a history of stable ...
Read Full Story »

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan PLC (NYSE: AGN) finally has announced that its shareholders have voted to approve the company’s acquisition by AbbVie Inc. (NYSE: ABBV). The acquisition is expected to close in early ...
Read Full Story »

Big Pharma Sees Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

The week of September 28, 2019, was a volatile one due to headlines about climate change discussions, the ongoing trade war with China and a potential presidential impeachment. It happened ...
Read Full Story »

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

With the final quarter of 2019 beginning next Tuesday, many investors are taking a long hard look at their portfolios and trying to make some adjustments. While the end of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

The futures traded higher Thursday morning as investors continue to try and discern exactly what the Democrats' impeachment plans are. The market had a strong reversal yesterday after President Trump ...
Read Full Story »

Short Sellers Grow More Selective in Big Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

Stocks were indicated to open higher on Thursday, and the S&P 500 is again within 1% of its all-time high. The markets have been volatile, and it's impossible to forget ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Big Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

Stocks closed 1% lower on the Dow Jones industrial average and 0.7% lower on the S&P 500 in Tuesday's post-tariff trading session, but most of those losses were being made ...
Read Full Story »

Big Pharma Sees a Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

Even though interest rates have plunged back to the levels seen six and seven years ago, the reality is that we are in some of the lowest rate levels in ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Last week's worst one-day sell-off was followed by three straight days of rallies, and the losses have been effectively wiped out. Stocks were indicated to open marginally higher on Tuesday ...
Read Full Story »

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Over the past three decades, the unlimited investing potential of biotechnology was all about growth. Companies could grow from nothing to see untold billions of dollars selling cures and treatments ...
Read Full Story »

Major Pharma Sees Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »